Cathrine Lundgaard Riis

ORCID: 0000-0003-0740-9207
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Cancer survivorship and care
  • Cancer Treatment and Pharmacology
  • Cancer-related cognitive impairment studies
  • Oral and Craniofacial Lesions
  • Drug-Induced Ocular Toxicity
  • Multiple Myeloma Research and Treatments
  • Oral health in cancer treatment
  • Advanced Breast Cancer Therapies
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Global Cancer Incidence and Screening
  • Head and Neck Cancer Studies

Lillebaelt Hospital
2018-2025

University of Southern Denmark
2020-2021

Vejle Sygehus
2019

Recent evidence suggests that atorvastatin exacerbates paclitaxel neurotoxicity via P-glycoprotein inhibition. We used a translational approach to investigate if or simvastatin (i) in human sensory neurons and (ii) paclitaxel-induced peripheral neuropathy (PIPN) cancer patients. Paclitaxel was assessed by quantifying neuronal networks of induced pluripotent stem cell-derived (iPSC-SNs) with without exposure. estimated the odds ratio (OR) early discontinuation due PIPN nationwide cohort...

10.1111/bcpt.70022 article EN cc-by-nc Basic & Clinical Pharmacology & Toxicology 2025-03-27

Background: The population of breast cancer survivors is increasing as a positive consequence early detection and enhanced treatment. disease treatment associated side-effects or late-effects often impact on quality life daily functions during survivorship. This calls for optimization follow-up care. We aimed to evaluate the patients' satisfaction with care provided, when using electronic patient reported outcomes (ePROs) individualize in women receiving adjuvant endocrine therapy.Material...

10.1080/0284186x.2020.1717604 article EN Acta Oncologica 2020-01-31

Patient-reported outcomes (PROs) are frequently used to evaluate treatment effects and quality of life in clinical trials. The application PROs breast cancer clinics is evolving but their use generate real-time information for follow-up care uncommon. This proactive might help shift healthcare delivery toward a more patient-centered approach by acting as screening tool unmet needs or dialogue discuss issues proposed the patient.

10.2147/prom.s195296 article EN cc-by-nc Patient Related Outcome Measures 2019-03-01

Baggrund. Mundgener er en kendt bivirkning til kemoterapi med beskadigelse af mundslimhinden. Oral mucositis kan blandt andet forårsage øm mund, mundtørhed, smerter, smagsforandringer, blødning og infektion, som føre nedsat fødeindtag dermed påvirke patientens ernæringstilstand velvære. Formål. Formålet var at undersøge, om hvid te i højere grad forebygger end standard mundpleje skylning salt/natron hos patienter. Design. Studiet blev gennemført et randomiseret kontrolleret...

10.62680/fa1224 article DA Deleted Journal 2024-04-29
Coming Soon ...